
This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring pharmaceutical, device, training and educational companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of confirmed sponsors for this event can be found on the website by clicking on the sponsors tab.
Register now for the 22nd National Conference of the Primary Care Diabetes & Obesity Society. Through our packed programme of lectures, debates, masterclasses and case studies, you will learn the latest evidence and guidelines to help you optimise your care of diabetes, obesity and metabolic disease. As the management of these conditions grows ever more complex, with new therapies, guidelines and structuring of services throughout the UK, our expert speakers will help you identify first principles to unravel these complexities of care.
To submit your poster entry please click the 'Poster Registration' button above. Poster entries due by 28th August 17:30: Click here for more information
Masterclasses offering hands-on tips that will influence your everyday clinical practice
Inspiration and new contacts with various opportunities to network alongside your peers
Claim 12 CPD points for this two-day conference, and receive a workbook to build your CPD profile, supplemented by associated online materials
22nd National Conference of the Primary Care Diabetes & Obesity Society 2026
Date: 18 & 19 November 2026 - Wednesday & Thursday
Location: NCC, Birmingham
We have some bedrooms on hold at the Manor Hotel - standard room rate of £150 BB per night. To book one of these rooms please call the hotel on 02476 208800 or 01676 526508 Monday to Friday between 9:00am and 5:00pm quoting ‘OmniaMed Allocation’.

Samina Ali
Advanced Practice Pharmacist, Glasgow

Sarah Alicea
Clinical Lead Diabetes Dietitian, Royal Free London NHS Trust, Barts Health NHS Trust

Hannah Beba
Consultant Pharmacist, West Yorkshire Health & Care Partnership

Heather Bell
GP Principal, Carrickfergus

Rachel Besser
Consultant Paediatric Diabetologist, Oxford Children's Hospital and Research Investigator, Nuffield Department of Medicine, University of Oxford

Pam Brown
GP, Swansea

Matt Capehorn
GP and Clinical Manager of Rotherham Institute for Obesity

Pratik Choudhary
Professor and Honorary Consultant in Diabetes, Diabetes Research Centre, University of Leicester

Sarah Davies
GP Partner, Woodlands Medical Centre, Cardiff

Lisa Devine
GP, Wicklow

Jane Diggle
Specialist Diabetes Nurse Practitioner, West Yorkshire

Dr James Dorling
Lecturer in Human Nutrition, Glasgow

Su Down
Diabetes Nurse Consultant, Somerset

Satish Durgam
GP Partner, London

Louisa Ells
Professor of Obesity & Co-director of the Obesity Institute, Leeds Beckett University

Andrew Frankel
Consultant Physician and Nephrologist, Imperial College Healthcare NHS Trust

Clare Hambling
GP, Norfolk, Chair of the PCDS and National Clinical Director for Diabetes and Obesity, NHS England

Lesley Hamilton
Diabetes Dietitian Specialist and Diabetes Network Manager, Western Trust

Wasim Hanif
Professor Diabetes & Endocrinology, Clinical Director, University Hospital Birmingham

Richard Holt
Professor in Diabetes and Endocrinology, University of Southampton

Naresh Kanumilli
GP with a Special Interest in Diabetes and Cardiology, Manchester and Chair of PCDO Society

Kamlesh Khunti
Professor of Primary Care Diabetes and Vascular Medicine, Leicester

Julie Lewis
Primary Care Nurse Consultant / Clinical Lead for Diabetes, North Wales

Lyndsey McConnell
GPwSI in Diabetes, Gartnavel General Hospital, Glasgow

David Miller
Clinical Pharmacist in General Practice, Beverley

Nicola Milne
Primary Care Diabetes Specialist Nurse Diabetes Specialist Nurse Clinical lead for the Greater Manchester Diabetes Strategic Clinical Network

Rahul Mohan
GPwER Diabetes, Nottingham and Secretary of the Primary Care Diabetes & Obesity Society

Paul Newman
GP, Glasgow

Una O'Neill
ANP Diabetes Integrated Care, HSE St Mary’s Community Services, Co. Kildare

Dipesh Patel
Consultant Physician in Diabetes and Endocrinology, London

Waqas Tahir
GPwER Diabetes, Affinity Care

Reena Patel
Specialist Nurse in Diabetes, Leicester

Jayne Robbie
Senior Lecturer & Course Lead, Birmingham City University; MSc in advancing practice in peripheral vascular disease

Professor Peter Schwarz
President of the International Diabetes Federation

Sam Seidu
GP and Primary Care Academic Diabetologist, Leicester

Rose Stewart
Consultant Clinical Psychologist

Stephen Wheatcroft
Professor of Cardiometabolic Medicine, University of Leeds. Consultant Cardiologist, Leeds Teaching Hospitals NHS Trust

Supporting the NHS to deliver sustainable healthcare solutions
At Daiichi Sankyo UK, we create and supply innovative products to help the NHS to deliver better patient care in the fields of cardiovascular disease and oncology.
Our mission is to contribute to the enrichment of quality of life through the discovery and delivery of innovative medicines that address diverse and unmet medical needs.
We strive to provide solutions to support high-quality and sustainable healthcare, including for the NHS dispensing surgery community.
For more information about Daiichi Sankyo visit https://www.daiichi-sankyo.co.uk
Abbott is a global healthcare leader that helps people live life to the full. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries.
At Abbott, we believe people with diabetes should enjoy active lives, so we’re focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology is revolutionising how people monitor their glucose and provides healthcare professionals with more data to make more informed treatment decisions.
© 2026 Abbott. ADC-129168 03/26 v1.0

At Dexcom, we believe that with diabetes, knowledge is power. We’ve spent the last 20 years innovating and developing simpler and better ways for people with type 1 diabetes to measure, track and manage their diabetes. When Dexcom was established the only way to measure glucose levels was to fingerstick, it gave us a snapshot not a story which made it difficult to understand our glucose levels and trends over time or feel in control of our diabetes. Since then, we’ve launched the world’s first real-time CGM system and helped to eliminate more than 11 billion fingersticks.

Lilly is a medicine company turning science into therapies to make life better for people around the world. We've been pioneering life-changing discoveries for nearly 150 years, and today our medicines help more than tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are advancing new discoveries to address some of the world's most significant health challenges.
We have been a global leader in diabetes since 1923, and are redefining diabetes and obesity care today. Through research, medicines, technologies, support programs and more, we strive to make life better for people living with diabetes and obesity.
To learn more, visit www.lilly.com/uk or www.linkedin.com/showcase/eli-lilly-and-company-uk-and-ireland/.

Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes.
To learn more, visit: https://www.novonordisk.co.uk/

A. Menarini Farmaceutica Internazionale SRL is the UK branch of the Menarini Group, Italy’s largest pharmaceutical company headquartered in Florence. We work to partner with the NHS, identifying opportunities where our products can make a real difference to patients’ lives in both primary and secondary care.
August 2025 | PP-MN-UK-0644





This conference was developed by the PCDO Society in conjunction with OmniaMed Communications. The sponsoring pharmaceutical, device, training and educational companies have contributed financial support towards this event but have had no input into the conference agenda, speaker selection or presentations, with the exception of the symposium sessions, for which the respective sponsoring companies are fully responsible. A full list of confirmed sponsors for this event can be found on the website by clicking on the sponsors tab.